Skip to main content

Table 1 Summary of baseline demographic characteristics

From: Pharmacokinetic interaction assessment of an HIV broadly neutralizing monoclonal antibody VRC07-523LS: a cross-protocol analysis of three phase 1 trials in people without HIV

Characteristic

Combination: VRC07-523LS with 1 or 2 other HIV mAbs, N = 46

Single: VRC07-523LS alone, N = 100

Sex assigned at birth

 Female [n (%)]

24 (52%)

61 (61%)

 Male [n (%)]

22 (48%)

39 (39%)

Weight (kg) [median, (range)]

71 (46, 109)

76 (48, 114)

Creatinine clearance (mL/min) [median, (range)]

120 (73, 183)

122 (66, 220)

Age (years) [median, (range)]

28 (19, 50)

28 (18, 50)

Country of study

 United States [n (%)]

46 (100%)

92 (92%)

 Switzerland [n (%)]

0 (0%)

8 (8%)